Advanced Analytical - A part of Agilent Revenue and Competitors

Ankeny, IA USA

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Advanced Analytical - A part of Agilent's estimated annual revenue is currently $4.3M per year.(i)
  • Advanced Analytical - A part of Agilent's estimated revenue per employee is $155,000

Employee Data

  • Advanced Analytical - A part of Agilent has 28 Employees.(i)
  • Advanced Analytical - A part of Agilent grew their employee count by 4% last year.

Advanced Analytical - A part of Agilent's People

NameTitleEmail/Phone
1
Research And Development ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.9M980%N/AN/A
#2
$16.1M884%N/AN/A
#3
$0.8M1742%$2.1MN/A
#4
$504.4M17756%$31.2MN/A
#5
$8.1M479%N/AN/A
#6
$2M1536%N/AN/A
#7
$0.3M20%N/AN/A
#8
$0.2M10%N/AN/A
#9
N/A5320%N/AN/A
#10
$1.8M2344%N/AN/A
Add Company

What Is Advanced Analytical - A part of Agilent?

We make analytical scientific instruments. In particular, we have a product family of capillary electrophoresis instruments including: Fragment Analyzer Automated CE System which can: • Quickly qualify and quantify NGS sample prep libraries prior to sequencing. • Analyze total RNA quality and quantity. • Assess genomic DNA up to 40,000bp • Resolve large fragments up to 20,000bp • Rapidly separate and analyze microsatellites, SSRs and PCR fragments. Fragment Analyzer -- a capillary electrophoresis instrument for analyzing DNA & RNA. ZAG - The Zero Agarose Gel DNA Analyzer -- provides automated high throughput fragment analysis for DNA. Oligo PRO -- a UV system for performing oligonucleotide purity analysis and RNAi analysis. pKa PRO -- a UV system for rapid pKA measurement and log P measurement.

keywords:N/A

N/A

Total Funding

28

Number of Employees

$4.3M

Revenue (est)

4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.9M3124%N/A
#2
$12.4M3812%N/A
#3
$11.6M4224%N/A
#4
$7.6M4310%N/A
#5
$7.4M480%N/A